Benefit from Roche's long lasting experience in PT/INR Monitoring
PT/INR Monitoring has always been a challenge to healthcare professionals and to their patients.
Usual care involves a venous blood sample or the patients themself being sent to a laboratory for a blood test (PT/INR). This is time-consuming and rather cumbersome, as it often requires a second appointment with the healthcare professional to adapt the VKA dosage. Patient’s compliance may be therefore limited over time, resulting in potential complications.
In contrast, Point of Care INR Monitoring with the CoaguChek systems provide within one minute accurate PT/INR results from a single drop of capillary blood from the fingertip, meaning that VKA therapy can be adjusted on the spot, either at the HCP’s or at home by selected and trained patients.
The next generation in POC PT/INR testing, the new CoaguChek XS System uses exclusive smart technology to help ensure accurate results, and offers the flexibility and control that healthcare professionals need to confidently manage a wide range of anticoagulated patients.
The new system offers healthcare professionals an easy and efficient way to obtain accurate PT/INR results quickly at the point of care so they can make immediate therapy adjustments, discuss them with the patient, and document treatment decisions – all in one appointment.